Black Rock Inc. Aclaris Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,032,155 shares of ACRS stock, worth $4.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,032,155

Previous 5,202,147 60.94%

Holding current value

$4.17 Million

Previous $6.45 Million 65.35%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$1.01 - $1.36 $3.2 Million - $4.31 Million	-3,169,992 Reduced 60.94%	2,032,155 $2.24 Million
Q1 2024 May 10, 2024	SELL	$0.92 - $1.44 $647,427 - $1.01 Million	-703,725 Reduced 11.92%	5,202,147 $6.45 Million
Q4 2023 Feb 13, 2024	BUY	$0.64 - $6.49 $190,708 - $1.93 Million	297,982 Added 5.31%	5,905,872 $6.2 Million
Q3 2023 Nov 13, 2023	BUY	$6.56 - $10.95 $89,983 - $150,201	13,717 Added 0.25%	5,607,890 $38.4 Million
Q2 2023 Aug 11, 2023	BUY	$7.89 - $10.64 $3.78 Million - $5.09 Million	478,800 Added 9.36%	5,594,173 $58 Million
Q1 2023 May 12, 2023	BUY	$7.07 - $17.95 $188,867 - $479,516	26,714 Added 0.52%	5,115,373 $41.4 Million
Q4 2022 Feb 13, 2023	BUY	$14.33 - $18.37 $3.99 Million - $5.11 Million	278,361 Added 5.79%	5,088,659 $80.1 Million
Q3 2022 Nov 14, 2022	BUY	$13.07 - $18.22 $1.83 Million - $2.56 Million	140,382 Added 3.01%	4,810,298 $75.7 Million
Q2 2022 Aug 12, 2022	BUY	$10.16 - $17.08 $6.94 Million - $11.7 Million	682,809 Added 17.13%	4,669,916 $65.2 Million
Q1 2022 May 12, 2022	SELL	$9.74 - $17.92 $893,820 - $1.64 Million	-91,768 Reduced 2.25%	3,987,107 $68.7 Million
Q4 2021 Feb 10, 2022	BUY	$12.27 - $18.49 $3.56 Million - $5.37 Million	290,458 Added 7.67%	4,078,875 $59.3 Million
Q3 2021 Nov 09, 2021	BUY	$13.38 - $18.8 $7.35 Million - $10.3 Million	549,368 Added 16.96%	3,788,417 $68.2 Million
Q2 2021 Aug 11, 2021	BUY	$17.08 - $29.6 $55.3 Million - $95.9 Million	3,239,049 New	3,239,049 $56.9 Million

Others Institutions Holding ACRS

# of Institutions

Shares Held

50.7M

Call Options Held

30.6K

Put Options Held

View Full List

About Aclaris Therapeutics, Inc.

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $137M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

More about ACRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account